You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemokine

Showing 1 - 25 of 929
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Acute Graft Versus Host Disease

Not yet recruiting
  • GVHD,Acute
  • blood sample
  • Detroit, Michigan
    Henry Ford Health System
Jan 30, 2023

Tregs CD25 CXCL9 in Vitiligo

Not yet recruiting
  • Vitiligo
  • +3 more
  • ELIZA , Flowcytometry
  • (no location specified)
Oct 3, 2022

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023

COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • Candesartan Cilexetil
  • +3 more
  • Guntur, India
  • +4 more
Mar 13, 2022

Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

Recruiting
  • Lymphoma
  • +2 more
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Kidney Transplant; Complications, Rejection of Renal Transplant Trial in Australia, Canada (Kidney transplant biopsy)

Recruiting
  • Kidney Transplant; Complications
  • Rejection of Renal Transplant
  • Kidney transplant biopsy
  • Adelaide, South Australia, Australia
  • +6 more
May 24, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

CAP-100 for Relapsed/Refractory Chronic Lymphocytic Leukemia

Recruiting
  • Lymphocytic Leukemia, Chronic
  • SLL
  • Durham, North Carolina
  • +1 more
Sep 16, 2021

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Mogamulizumab
  • Pembrolizumab
  • Sacramento, California
  • +7 more
Sep 15, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

Completed
Has Results
  • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
  • +2 more
  • DC vaccine
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 6, 2020

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Multiple Myeloma, Lymphoma Trial in Beijing (68Ga-Pentixafor)

Unknown status
  • Multiple Myeloma
  • Lymphoma
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Dec 26, 2019

Nutrition Disorders, Hypertension, Dyslipidemias Trial in Poznan (Blood sample collection, Hair sample collection, Urine sample

Unknown status
  • Nutrition Disorders
  • +7 more
  • Blood sample collection
  • +5 more
  • Poznan, Wielkopolska, Poland
    Department of Treatment of Obesity, Metabolic Disorders and Clin
Aug 13, 2020

Venous Ulcer, Sickle Cell Ulcer, Diabetic Ulcer Trial in Paris (Saliva sampling, Blood sampling, Interviews)

Not yet recruiting
  • Venous Ulcer
  • +3 more
  • Saliva sampling
  • +3 more
  • Paris, Ile De France, France
    Dermatology unit - Cochin Hospital - APHP
Sep 8, 2023

Relapsing Remitting Multiple Sclerosis Trial in Mecidiyekoy, Uskudar, Istanbul (Fingolimod 0.5 mg)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • Fingolimod 0.5 mg
  • Mecidiyekoy, Istanbul, Turkey
  • +2 more
Sep 3, 2019

Genetic Factors in Atherosclerosis

Completed
  • Atherosclerosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 14, 2019